{"schemaVersion":"411.history/1","type":"revision","id":"0d7be34d80bdf2da6719200501a79292c32a4800f0af0bccc2966ae0aa830b8a","itemId":"medworld411:e0518ddab32476cb72928c68","legacyId":"e0518ddab32476cb72928c68","nativeVersion":"history-v1:1","revision":1,"predecessor":null,"observedAt":"2026-11-21T02:50:31.410Z","contentHash":"e4d485201c21e1e8437c7ade56761e7bc2fefc53089e8dcfbe08e30178896a68","content":{"title":"FDA Grants Accelerated Approval to a New Treatment for Head and Neck Squamous Cell Carcinoma","url":"http://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-new-treatment-head-and-neck-squamous-cell-carcinoma","sourceId":"fda","sourceName":"FDA","publishedAt":"2026-11-05T22:30:38.000Z","publishedDate":null,"publishedRaw":"Thu, 05 Nov 2026 17:30:38 EST","updatedRaw":null,"kind":"Official release","deadline":null,"topics":["care"],"section":"policy","classifierVersion":"medworld411.topics/1","vertical":null,"primaryUrl":"http://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-new-treatment-head-and-neck-squamous-cell-carcinoma","coverageUrl":null},"provenance":{"captureScope":"headline-metadata","publisherEditTimeKnown":false,"importedAt":null,"completeness":"forward-capture-baseline; older native history retained separately"},"release":"0.2.1-vertical.1"}